InsidersTradesSigma
Scandinavian ChemoTech AB Stock: price and insider trades · Finland · FIN-FSA
Track the Scandinavian ChemoTech AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Scandinavian ChemoTech AB has recorded 2 insider filings. Market capitalisation: €98.3m. The latest transaction was disclosed on 17 June 2026 (Purchase). Among the most active insiders: APAC EQUITY MANAGEMENT PTE LTD. All data is openly available.
2
Insider Decl.
0
Thresholds
€72,847
2 ops.
Buy Volume
·
0 ops.
Sell Volume
37Σ signal
Fundamental score
Ranked 22,119 of 25,899 companies
26.3
score / 100
Value21
Quality32
FCF yld-4.3%
Earn yld-8.4%
EV/EBITDA·
ROE-236%
Gross mgn84%
Net mgn-66%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 17 June 2026
Declarations2 total
223,880 shares@ SEK 3.350.074% mcap93.9% of flowAktieFI:csv-00f6ecccfdaced2fe37a
Ideal exit: 13 Mar 2027 (T+270)
12,611 shares@ €0.35030.0048% mcap100.0% of flowAktieFI:A003U613-1
Ideal exit: 7 Sept 2026 (T+270)
2 of 2 declarations
About Scandinavian ChemoTech AB
Scandinavian ChemoTech AB is a company focused on developing innovative cancer treatments. It specializes in enhanced chemotherapy solutions and targeted treatment technologies.